We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

TOO FIT TO FRACTURE Evidence based recommendations to help reduce the risk of fractures Exercises for Healthy Bones The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

2023 Clinical Practice Guideline Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. This guideline is an update of the 2010 Osteoporosis Canada clinical practice […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]